Skip to main content

The “Company Name” field currently displays the company associated with the drug identification number (DIN) as of today. A fix will be implemented shortly so the fields will show the company name as it was when the report was originally posted. This issue does not impact the data that can be extracted from the website using the Application Programming Interface (API).

Reports for GABAPENTIN

Ingredient

GABAPENTIN

Shortage reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
RAN-GABAPENTIN	300MG	CAPSULE	Resolved	2017-03-13	2019-02-01	1546
RAN-GABAPENTIN	100MG	CAPSULE	Resolved	2017-08-16	2019-02-04	19636
RIVA-GABAPENTIN	600MG	TABLET	Actual shortage	2017-03-13	2017-10-05	1575
RIVA-GABAPENTIN	800MG	TABLET	Actual shortage	2017-03-13	2017-10-05	1580
TEVA-GABAPENTIN	400MG	CAPSULE	Resolved	2023-01-19	2023-04-28	181617
TEVA-GABAPENTIN	300MG	CAPSULE	Resolved	2025-04-04	2025-06-27	254130
TEVA-GABAPENTIN	400MG	CAPSULE	Resolved	2023-02-09	2023-04-28	184189
TEVA-GABAPENTIN	400MG	CAPSULE	Resolved	2024-08-08	2024-09-12	234879
TEVA-GABAPENTIN	400MG	CAPSULE	Resolved	2025-08-29	2025-09-04	266184
TEVA-GABAPENTIN	400MG	CAPSULE	Resolved	2025-10-10	2025-12-05	269232

Previous
1
…
14
15
16
17
18
…
20
Next

Showing 151 to 160 of 199

Discontinuation reports
Brand name	Strength	Dosage	Status	Date Created	Date Updated	Reports
RAN-GABAPENTIN	400MG	CAPSULE	Discontinued	2019-03-29	2019-03-29	80051

Showing 11 to 11 of 11